ATE360644T1 - Vegf-peptide und deren verwendung - Google Patents

Vegf-peptide und deren verwendung

Info

Publication number
ATE360644T1
ATE360644T1 AT03745335T AT03745335T ATE360644T1 AT E360644 T1 ATE360644 T1 AT E360644T1 AT 03745335 T AT03745335 T AT 03745335T AT 03745335 T AT03745335 T AT 03745335T AT E360644 T1 ATE360644 T1 AT E360644T1
Authority
AT
Austria
Prior art keywords
vegf peptides
vegf
peptides
sckntdsrckarqlelnertcrcdkprr
fragment
Prior art date
Application number
AT03745335T
Other languages
English (en)
Inventor
D Wolfson Selwood
M Wolfson Loehr
I Wolfson Zachary
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Application granted granted Critical
Publication of ATE360644T1 publication Critical patent/ATE360644T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03745335T 2002-04-02 2003-03-28 Vegf-peptide und deren verwendung ATE360644T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207644.6A GB0207644D0 (en) 2002-04-02 2002-04-02 Peptides and their use

Publications (1)

Publication Number Publication Date
ATE360644T1 true ATE360644T1 (de) 2007-05-15

Family

ID=9934136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03745335T ATE360644T1 (de) 2002-04-02 2003-03-28 Vegf-peptide und deren verwendung

Country Status (17)

Country Link
US (1) US20060166868A1 (de)
EP (1) EP1490401B1 (de)
JP (1) JP2005531527A (de)
KR (1) KR100641535B1 (de)
CN (1) CN1642979A (de)
AT (1) ATE360644T1 (de)
AU (1) AU2003226515B2 (de)
CA (1) CA2481253A1 (de)
DE (1) DE60313444T2 (de)
ES (1) ES2283799T3 (de)
GB (1) GB0207644D0 (de)
IL (1) IL163799A0 (de)
MX (1) MXPA04009479A (de)
NO (1) NO20044105L (de)
PL (1) PL371546A1 (de)
WO (1) WO2003082918A1 (de)
ZA (1) ZA200406922B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795213B2 (en) 2001-12-13 2010-09-14 Posco Methods of contacting β amyloid protein with VEGF
WO2005030243A1 (en) * 2003-09-26 2005-04-07 Bristol Myers Squibb Company Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
CN1904150B (zh) * 2006-08-01 2010-07-28 华东师范大学 一种人胰高血糖素样肽-1衍生物及其固相化学合成
GB0619611D0 (en) 2006-10-04 2006-11-15 Ark Therapeutics Ltd Compounds and their use
GB0619609D0 (en) * 2006-10-04 2006-11-15 Ark Therapeutics Ltd Compounds and their use
CN104774246B (zh) * 2014-03-21 2018-05-04 中山大学附属肿瘤医院 Nrp-1特异性肿瘤靶向多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2874292A (en) * 1991-10-24 1993-05-21 Beth Israel Hospital Association, The Assay for malignant effusions
CA2313390A1 (en) * 1997-12-09 1999-06-17 Children's Medical Center Corporation Peptide antagonists of vascular endothelial growth factor
WO2001052875A1 (en) * 2000-01-18 2001-07-26 Ludwig Institute For Cancer Research Vegf-d/vegf-c/vegf peptidomimetic inhibitor

Also Published As

Publication number Publication date
AU2003226515A1 (en) 2003-10-13
EP1490401A1 (de) 2004-12-29
NO20044105L (no) 2004-10-27
ZA200406922B (en) 2006-06-28
KR100641535B1 (ko) 2006-10-31
AU2003226515B2 (en) 2006-06-08
WO2003082918A1 (en) 2003-10-09
GB0207644D0 (en) 2002-05-15
MXPA04009479A (es) 2005-01-25
US20060166868A1 (en) 2006-07-27
ES2283799T3 (es) 2007-11-01
CN1642979A (zh) 2005-07-20
DE60313444T2 (de) 2007-08-30
PL371546A1 (en) 2005-06-27
EP1490401B1 (de) 2007-04-25
DE60313444D1 (de) 2007-06-06
JP2005531527A (ja) 2005-10-20
CA2481253A1 (en) 2003-10-09
KR20040099356A (ko) 2004-11-26
IL163799A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
CY1107248T1 (el) Συντηγμενες πρωτεϊνες
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
DE60315296D1 (de) Zell-selektives Abgabe System
CY1117551T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
EP1487493A4 (de) Konjugate von therapeutischen oder zytotoxischen mitteln und biologisch aktiven peptiden
EP1732581A4 (de) Polypeptidtransduktion und fusogene peptide
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
AU2003228809A8 (en) Kinase anchor protein muteins, peptides thereof, and related methods
NZ598176A (en) Disintegrin variants and pharmaceutical uses thereof
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
NO20063026L (no) Antistoffer
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
ATE360644T1 (de) Vegf-peptide und deren verwendung
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
ATE336501T1 (de) Chi-conotoxinpeptide als inhibitoren neuronaler amintransporter
ATE554102T1 (de) Therapeutische verwendungen von monoklonalen antikörpern gegen den angiotensin-ii typ-1 rezeptor
NO20054668L (no) Aplidin for multippelt myelom-behandling
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
NO20082864L (no) Nytt polypeptid med esteraseaktivitet og rekombinant esterase samt anvendelse derav
MXPA05008378A (es) Inmunoglobulina anti-intregrina.
EP1566386A4 (de) Gen in zusammenhang mit haarausfall, das davon kodierte polypeptid und anwendungen dafür
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties